172 related articles for article (PubMed ID: 15857318)
1. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
Kirby M
Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
[No Abstract] [Full Text] [Related]
2. The impact of publishing medical specialty society guidelines on subsequent adoption of best practices: a case study with type 2 diabetes.
Huang EA; Zdon GS; Moore RJ; Jane Moran H; Quick WW
Int J Clin Pract; 2010 Apr; 64(5):558-61. PubMed ID: 20456210
[TBL] [Abstract][Full Text] [Related]
3. Patients with both diabetes and heart failure often treated with medications government considers unsafe.
Levenson D
Rep Med Guidel Outcomes Res; 2003 Aug; 14(15):1, 6-7. PubMed ID: 12964577
[No Abstract] [Full Text] [Related]
4. Intensifying type 2 diabetes therapy: assessing the options. Introduction.
Brunton SA
J Fam Pract; 2011 Sep; 60(9 Suppl):S3. PubMed ID: 21912772
[No Abstract] [Full Text] [Related]
5. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
Almirall J; Bricullé M; Gonzalez-Clemente JM
Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
[No Abstract] [Full Text] [Related]
6. Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitus.
Grant PJ
Thromb Haemost; 1998 Jul; 80(1):209-10. PubMed ID: 9684819
[No Abstract] [Full Text] [Related]
7. Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
[No Abstract] [Full Text] [Related]
8. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
9. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
Halimi S
Diabetes Metab; 2006 Dec; 32(6):555-6. PubMed ID: 17296508
[No Abstract] [Full Text] [Related]
10. Choosing first-line therapy for management of type 2 diabetes.
Graber MA; Darby-Stewart A; Dachs R
Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
[No Abstract] [Full Text] [Related]
11. [Metformin role in the treatment of type 2 diabetes in 2008].
Spada A; Philippe J
Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
[TBL] [Abstract][Full Text] [Related]
12. The perioperative management of metformin for the oral and maxillofacial surgery patient: risks and recommendations.
Blyer SM; Yelon JA
J Oral Maxillofac Surg; 2007 Jan; 65(1):122-7. PubMed ID: 17174776
[No Abstract] [Full Text] [Related]
13. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy in patients with type 2 diabetes complicated by heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066
[No Abstract] [Full Text] [Related]
15. [The practice guideline 'Diabetes mellitus type 2' (second revision) from the Dutch College of General Practitioners; a response from the perspective of general practice].
Bouma M; Rutten GE; Wiersma T
Ned Tijdschr Geneeskd; 2006 Oct; 150(42):2339-40. PubMed ID: 17091545
[No Abstract] [Full Text] [Related]
16. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
Scherbaum WA
Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
[No Abstract] [Full Text] [Related]
17. [Metformin undervalued].
Stumvoll M; Fritsch A
Dtsch Med Wochenschr; 1996 Mar; 121(10):A8-9. PubMed ID: 8681710
[No Abstract] [Full Text] [Related]
18. Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq.
Mansour AA; Habib OS
Saudi Med J; 2007 Dec; 28(12):1919-21. PubMed ID: 18060234
[No Abstract] [Full Text] [Related]
19. Do we need new drugs for the treatment of type 2 diabetes mellitus?
Vervoort G; Tack CJ
Neth J Med; 2007 May; 65(5):157-9. PubMed ID: 17519510
[No Abstract] [Full Text] [Related]
20. Follow-up of intensive glucose control in type 2 diabetes.
Petrie JR
N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
[No Abstract] [Full Text] [Related]
[Next] [New Search]